Mezoridazin Садржај Osobine Reference Literatura Spoljašnje veze Мени за навигацијуMonografija5588-33-0WHO4078DB009333936C07143CHEBI:6780CHEMBL1088„DrugBank 3.0: a comprehensive resource for omics research on drugs”30137092105968210.1093/nar/gkq1126„DrugBank: a knowledgebase for drugs, drug actions and drug targets”22388891804841210.1093/nar/gkm958„Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”10.1021/jp980230o„Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”1174957310.1021/ci000392t„Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”1102028610.1021/jm000942eGoodman & Gilman's The Pharmacological Basis of Therapeutics10.1036/0071422803Foye's Principles of Medicinal ChemistryMezoridazinVikimedijinoj ostaviMesoridazineу
АнтипсихотициДопамински антагонистиПиперидиниСулфоксидиТиоетри
organsko jedinjenjeatomugljenikamolekulsku masuDaAzaperonBenperidolBromperidolDroperidolFluanizonHaloperidolLenperonMoperonPipamperonSpiperonTimiperonTrifluperidolKlopimozidFluspirilenPenfluridolPimozidAcepromazinAcetofenazinButaperazinKarfenazinHloracizinHlorproetazinHlorpromazinCijamemazinDiksirazinFluacizinFlufenazinLevomepromazin/MetotrimeprazinMezoridazinPerazinPericijazinPerfenazinPiperacetazinPipotiazinProhlorperazinPromazinPrometazinPropiomazinSulforidazinTietilperazinTiopropazatTioproperazinTioridazinTrifluoperazinTriflupromazinHlorprotiksenKlopentiksolFlupentiksolTiotiksenZuklopentiksolButaklamolFluotracenLoksapinTrimipraminCinuperonMelperonSetoperonIloperidonOkaperidonPaliperidonRisperidonLurasidonePerospironRevospironTiospironZiprasidonAmperozidAripiprazolBifeprunoksBrekspiprazolElopiprazolUmespironAmoksapinAsenapinKarpipraminKlocapraminKlorotepinKlotiapinKlozapinFluperlapinGevotrolinMetitepinMosapraminNDMCOlanzapinPihindonKvetijapinTenilapinZotepinWHO-EMPovučeniKlinička ispitivanjaFaza IIINije dospeo do faze IIIMPSOPSImeprdsrdodbpasspecspvoprocN5A5B5C6A6B6D
(function()var node=document.getElementById("mw-dismissablenotice-anonplace");if(node)node.outerHTML="u003Cdiv class="mw-dismissable-notice"u003Eu003Cdiv class="mw-dismissable-notice-close"u003E[u003Ca tabindex="0" role="button"u003Eсакријu003C/au003E]u003C/divu003Eu003Cdiv class="mw-dismissable-notice-body"u003Eu003Cdiv id="localNotice" lang="sr" dir="ltr"u003Eu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EУчествуј у u003Cbu003Eu003Ca href="https://meta.wikimedia.org/wiki/%D0%92%D0%B5%D0%BB%D0%B8%D0%BA%D0%BE_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%BD%D0%BE_%D1%81%D1%80%D0%B5%D1%92%D0%B8%D0%B2%D0%B0%D1%9A%D0%B5_%D0%9E%D1%81%D1%82%D0%B0%D0%B2%D0%B5" class="extiw" title="meta:Велико пролећно сређивање Оставе"u003EВеликом пролећном сређивању Оставеu003C/au003Eu003C/bu003E од 15. марта до 15. априла!u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Enu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EТакмичи се у писању u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%A2%D0%B0%D0%BA%D0%BC%D0%B8%D1%87%D0%B5%D1%9A%D0%B5_%D1%83_%D0%BF%D0%B8%D1%81%D0%B0%D1%9A%D1%83_%D1%87%D0%BB%D0%B0%D0%BD%D0%B0%D0%BA%D0%B0/%D0%A6%D0%95%D0%95_%D0%BF%D1%80%D0%BE%D0%BB%D0%B5%D1%9B%D0%B5_2019" title="Википедија:Такмичење у писању чланака/ЦЕЕ пролеће 2019"u003Eчланака о средњој и источној Европиu003C/au003Eu003C/bu003E од 21. марта до 31. маја!u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Enu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EУ току су расправе о u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B5%D0%B4%D0%BB%D0%BE%D0%B3/%D0%A3%D0%B2%D0%BE%D1%92%D0%B5%D1%9A%D0%B5_%D0%BE%D0%BF%D1%88%D1%82%D0%B5_%D0%BF%D1%80%D0%B8%D0%BF%D1%80%D0%B5%D0%BC%D0%B5" title="Википедија:Гласање/Предлог/Увођење опште припреме"u003Eувођењу опште припремеu003C/au003Eu003C/bu003E и u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D1%80%D0%B5%D0%B4%D0%BB%D0%BE%D0%B3/%D0%9F%D1%80%D0%B0%D0%B2%D0%BE_%D0%B0%D0%B4%D0%BC%D0%B8%D0%BD%D0%B8%D1%81%D1%82%D1%80%D0%B0%D1%82%D0%BE%D1%80_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D1%84%D0%B5%D1%98%D1%81%D0%B0" title="Википедија:Гласање/Предлог/Право администратор интерфејса"u003Eадминистраторима интерфејсаu003C/au003Eu003C/bu003E.u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Enu003Cdiv class="noticebanner"u003Eu003Cdiv class="plainlinks" style="background-image: -moz-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -o-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: -webkit-linear-gradient(top, #fefefe, #fefefe, #f0f0f0); background-image: linear-gradient(to bottom, #fefefe, #fefefe, #f0f0f0);; -moz-border-radius: 10px; -webkit-border-radius: 10px; border-radius:10px; margin-top:10px; position:relative; height:25px; border-style:solid; border-width:1px; color:#aaa; border-color:u0026#32;; border:; font-family: u0026#39;Helveticau0026#39;, u0026#39;Arialu0026#39;, sans-serif; line-height: 18px; background-color:; overflow:hidden;"u003Eu003Cdiv style="display:block; position: absolute; top:4px; width:100%; text-align:center;;"u003Eu003Cdiv style="font-weight:bold; color:#000085; font-size:14px; line-height:25px"u003Eu003Cdiv style="padding-left:50px;"u003Eu003C/divu003Eu003C/divu003Eu003Cdiv style="margin-top: 2px; font-weight:normal; color:#555; font-size:15px; line-height:15px;"u003Eu003Cdiv style="padding-left:50px;"u003EУ току је гласање о u003Cbu003Eu003Ca href="/wiki/%D0%92%D0%B8%D0%BA%D0%B8%D0%BF%D0%B5%D0%B4%D0%B8%D1%98%D0%B0:%D0%93%D0%BB%D0%B0%D1%81%D0%B0%D1%9A%D0%B5/%D0%9F%D0%BE%D0%B2%D0%B5%D1%9B%D0%B0%D1%9A%D0%B5_%D0%BF%D1%80%D0%BE%D1%81%D1%82%D0%BE%D1%80%D0%B0_%D0%B7%D0%B0_%D1%81%D0%BB%D0%B8%D0%BA%D0%B5_%D0%BD%D0%B0_%D0%B3%D0%BB%D0%B0%D0%B2%D0%BD%D0%BE%D1%98_%D1%81%D1%82%D1%80%D0%B0%D0%BD%D0%B8" title="Википедија:Гласање/Повећање простора за слике на главној страни"u003Eповећању простора за слике на Главној страниu003C/au003Eu003C/bu003E.u003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003Eu003C/divu003E";());
Mezoridazin
Иди на навигацију
Иди на претрагу
 | |
 | |
| Klinički podaci | |
|---|---|
| Prodajno ime | Calodal, Lidanar, Lidanil, Serentil |
| Drugs.com | Monografija |
| Način primene | Intramaskularno, oralno |
Farmakokinetički podaci | |
| Poluvreme eliminacije | 24 - 48 h |
| Identifikatori | |
| CAS broj | 5588-33-0  Y |
| ATC kod | N05AC03 (WHO) |
| PubChem | CID 4078 |
| DrugBank | DB00933 Y |
| ChemSpider | 3936 Y |
| KEGG | C07143 Y |
| ChEBI | CHEBI:6780 Y |
| ChEMBL | CHEMBL1088 Y |
| Hemijski podaci | |
| Formula | C21H26N2OS2 |
| Molarna masa | 386,574 |
SMILES
| |
InChI
| |
Mezoridazin je organsko jedinjenje, koje sadrži 21 atom ugljenika i ima molekulsku masu od 386,574 Da.[1][2]
Садржај
1 Osobine
2 Reference
3 Literatura
4 Spoljašnje veze
Osobine
| Osobina | Vrednost |
|---|---|
| Broj akceptora vodonika | 4 |
| Broj donora vodonika | 0 |
| Broj rotacionih veza | 4 |
Particioni koeficijent[3] (ALogP) | 4,5 |
Rastvorljivost[4] (logS, log(mol/L)) | -5,4 |
Polarna površina[5] (PSA, Å2) | 68,1 |
Reference
^ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035—41. PMC 3013709
. PMID 21059682. doi:10.1093/nar/gkq1126.
^ David S. Wishart; Craig Knox; An Chi Guo; Dean Cheng; Savita Shrivastava; Dan Tzur; Bijaya Gautam; Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic acids research. 36 (Database issue): D901—6. PMC 2238889. PMID 18048412. doi:10.1093/nar/gkm958.
^ Ghose, A.K.; Viswanadhan V.N. & Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A. 102: 3762—3772. doi:10.1021/jp980230o.
^ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
^ Ertl P.; Rohde B.; Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714—3717. PMID 11020286. doi:10.1021/jm000942e.
Literatura
.mw-parser-output .refbeginfont-size:90%;margin-bottom:0.5em.mw-parser-output .refbegin-hanging-indents>ullist-style-type:none;margin-left:0.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>ddmargin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none.mw-parser-output .refbegin-100font-size:100%
Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.
Spoljašnje veze
 | Mezoridazin na Vikimedijinoj ostavi. |
- Mesoridazine
 | Molimo Vas, obratite pažnju na važno upozorenje u vezi sa temama iz oblasti medicine (zdravlja). |
Категорије:
- Антипсихотици
- Допамински антагонисти
- Пиперидини
- Сулфоксиди
- Тиоетри
(window.RLQ=window.RLQ||[]).push(function()mw.config.set("wgPageParseReport":"limitreport":"cputime":"0.624","walltime":"0.780","ppvisitednodes":"value":4189,"limit":1000000,"ppgeneratednodes":"value":0,"limit":1500000,"postexpandincludesize":"value":132858,"limit":2097152,"templateargumentsize":"value":5848,"limit":2097152,"expansiondepth":"value":17,"limit":40,"expensivefunctioncount":"value":0,"limit":500,"unstrip-depth":"value":0,"limit":20,"unstrip-size":"value":10128,"limit":5000000,"entityaccesscount":"value":1,"limit":400,"timingprofile":["100.00% 645.060 1 -total"," 39.99% 257.931 1 Шаблон:Drugbox-lat"," 33.98% 219.164 3 Шаблон:Infobox"," 23.07% 148.819 1 Шаблон:Reflist"," 17.30% 111.606 4 Шаблон:Cite_pmid"," 17.24% 111.218 5 Шаблон:Cite_journal"," 13.14% 84.729 1 Шаблон:Commonscat-lat"," 8.99% 57.996 1 Шаблон:Cite_pmid/21059682"," 8.72% 56.259 1 Шаблон:Antipsihotici-lat"," 8.41% 54.223 2 Шаблон:Navbox"],"scribunto":"limitreport-timeusage":"value":"0.239","limit":"10.000","limitreport-memusage":"value":4060414,"limit":52428800,"cachereport":"origin":"mw1319","timestamp":"20190406120842","ttl":2592000,"transientcontent":false);mw.config.set("wgBackendResponseTime":119,"wgHostname":"mw1258"););
